By Debbie Lawes
A Toronto start-up company commercializing a new delivery system for cancer drugs has received $500,000 from the Ontario Institute for Cancer Research (OICR), one of the last awards to be made by the institute pending renewed funding from the Ontario Ministry of Research and Innovation.